心脉隆注射液联合左西孟旦治疗老年急性心肌梗死后心力衰竭患者的疗效观察

发布时间：2018-10-09 12:00

【摘要】：目的:观察心脉隆注射液联合左西孟旦对急性心肌梗死后心力衰竭老年患者的疗效。方法:对我院心血管内科2015年2月~2016年12月收治的86例急性心肌梗死后心力衰竭老年患者进行分组,各43例。两组均给予左西孟旦等常规治疗药物,观察组另给予心脉隆注射液,分析该注射液对该疾病的效果。结果:(1)观察组总有效率为93.02%,明显高于对照组72.09%。经治疗,观察组LVEF、LVEDD和LVESD分别为(55.09±3.39%、53.49±2.04mm、41.19±1.52mm),均明显优于对照组(50.27±3.29%、56.39±2.11mm、44.01±1.76mm)。(3)经治疗,观察组NT-pro BNP、CK-MB和c Tn I水平分别为(658.3±29.4μg/L、19.48±2.86U/L、0.10±0.05μg/L),均明显低于对照组(713.9±34.8μg/L、24.15±2.97U/L、0.18±0.07μg/L)(均P0.05)。(4)经治疗,观察组血清CRP、TNF-ɑ、IL-6水平分别为(3.17±1.09mg/L、364.1±23.1pg/ml、25.57±3.17ng/L),均明显低于对照组(5.06±1.15mg/L、485.7±25.4pg/ml、31.04±3.32ng/L)。(5)两组各不良反应率的差异均无统计学意义。结论:心脉隆注射液可减轻急性心肌梗死后心力衰竭老年患者的心肌损伤程度,提高其治疗效果。
[Abstract]:Objective: to observe the effect of Xinmailong injection combined with levosimendan on elderly patients with heart failure after acute myocardial infarction. Methods: 86 elderly patients with heart failure after acute myocardial infarction were divided into two groups, 43 cases in each group from February 2015 to December 2016. Both groups were treated with levosimendan and other conventional treatment drugs, and the observation group were treated with Xinmaolong injection. The effect of this injection on the disease was analyzed. Results: (1) the total effective rate of the observation group was 93.02, which was significantly higher than that of the control group (72.09). 缁忔不鐤，

本文编号：2259258